Company intelligence / Profile preview

Wavegate

Lake Charles, Louisiana, United Stateswavegate.us ↗

Ownership: Private
Development stage: Preclinical

Overview

Wavegate has developed the Ellipse Spinal Cord Stimulator Platform with proprietary StimuLux optical reflectometry for closed-loop adaptive neuromodulation. The system maintains a consistent therapeutic dose by tracking spinal cord movement in real time. The platform has received FDA Breakthrough Device designation and recently reported successful first-in-human data, supporting its potential to improve chronic pain management outcomes. Series A funding is accelerating further development and regulatory progress.

Therapeutic areas: Neurology
Modalities: DeviceNeuromodulation device (Spinal cord stimulator)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Ellipse

Pre-clinical

Indications: Chronic pain, Chronic back pain, Chronic leg pain

Partnerships

UCEA Capital Partners Ltd. (lead investor in Series A round)

Beyond the preview

Go deeper on Wavegate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wavegate.

Explore the full profile